Advertisement
Product › Details
Jyseleca®
Next higher product group | filgotinib (GLPG0634) | |
Status | 2020-09-25 registration start | |
Organisation | Galapagos N.V. (Euronext + Nasdaq: GLPG) | |
Group | Galapagos (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for filgotinib (GLPG0634)
- [1] Galapagos N.V.. (8/30/21). "Press Release: Galapagos Announces Planned Retirement of CEO". Mechelen....
- [2] Galapagos N.V.. (12/15/20). "Press Release: Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca (filgotinib)". Foster City, CA & Mechelen....
- [3] Galapagos N.V.. (8/19/20). "Press Release: Galapagos Announces that Gilead Received a Complete Response Letter for Filgotinib for the Treatment of Moderately to Severely Active Rheumatoid Arthritis". Mechelen....
- [4] Galapagos N.V.. (1/23/20). "Press Release: Galapagos Appoints Michele Manto as Chief Commercial Officer". Mechelen....
- [5] Galapagos N.V.. (10/10/19). "Press Release: Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis". Foster City, CA & Mechelen....
- [6] Galapagos N.V.. (8/28/19). "Press Release: Transparency Notification – Gilead Holds 22% of Galapagos Shares". Mechelen....
- [7] Galapagos N.V.. (8/23/19). "Press Release: Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration". Foster City, CA & Mechelen....
- [8] Galapagos N.V.. (8/15/19). "Press Release: European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis". Foster City, CA & Mechelen....
- [9] Financieele Dagblad (FD.nl) [de Lange, Rob]. (7/19/19). "News: Codename »Eagles«: the Making of Galapagos’ Unprecendeted Billion-Dollar Pact with Gilead"....
- [10] Galapagos N.V.. (7/14/19). "Press Release: Gilead and Galapagos Enter into Transformative Research and Development Collaboration". Foster City, CA & Mechelen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top